Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

NCT05969275 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

296

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock
Sepsis
Pathologic Processes
Shock
Systemic Inflammatory Response Syndrome
Inflammation
Infections

Interventions

BIOLOGICAL: Allogeneic umbilical cord-derived human mesenchymal stromal cells
OTHER: Placebo

Sponsor

Ottawa Hospital Research Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]